That article was
only about
primary IMRT or 3DCRT.
What I wrote was:
"Most of the later-term side effect data are given as their absolute incidence (a number at a particular time after treatment). Some side effects are given as increases over baseline function (indicated by “+” symbol). Unless otherwise specified, these are also acute side effects (within 3 months of treatment), rather than late-term or chronic side effects. Acute side effects are typically transient. Contrary to “common knowledge,” new side effects rarely emerge after 2 years."
Also note:
"None of these data necessarily apply to either stereotactic body radiation therapy (SBRT) or any form of brachytherapy."
For the longest f/u SBRT, read the following:
SBRT 7 yr QOL resultsPatient-reported urinary QOL scores dipped acutely and quickly returned to baseline. As you can see for yourself:
www.ncbi.nlm.nih.gov/pmc/articles/PMC4211385/figure/F3/Late term physician-reported urinary SEs were very rare:
"Late Grade 3 toxicity occurred in nine patients (1.7%) and consisted of either urinary retention requiring surgery or bleeding requiring laser coagulation."
Similar results are seen in other studies:
Quality of life after three different first-line radiation therapies for localized disease: Part 2